Objective: To characterize a novel secreted frizzled-related protein (SFRP)
and determine its tissue distribution at the mRNA and protein level.
Methods: The FrzB-2 gene was identified by expressed sequence tag (EST) ana
lysis of human tissue-derived libraries. Tissue distribution of FrzB-2 mRNA
was determined by Northern blot analysis and in situ hybridization. FrzB-2
protein reactivity was localized in human OA articular cartilage by immuno
cytochemistry, using a polyclonal antibody against a peptide sequence uniqu
e to FrzB-2. Apoptosis was detected in articular cartilage sections using T
unel staining.
Results: ESTs corresponding to FrzB-2 were found in osteoblast, chondrosarc
oma, osteosarcoma, osteoclastoma and synovial fibroblast libraries. FrzB-2
mRNA is expressed in a number of tissues and cell types including bone-rela
ted cells and tissues such as primary human osteoblasts and osteoclastoma.
In situ hybridization studies showed strong FrzB-2 mRNA expression in human
chondrocytes in human osteoarthritic (OA) cartilage but negligible levels
in normal cartilage chondrocytes. The FrzB-2 cDNA encodes a secreted 40 kDa
protein consisting of 346 amino acids. FrzB-2 is 92.5% identical to the ra
t orthologue, DDC-4, which has been shown to be associated with physiologic
al apoptosis. FrzB-2 protein was selectively detected in human OA articular
cartilage by immunocytochemistry, using a polyclonal antibody. Consistent
with its potential role in apoptosis, positive FrzB-2 staining and Tunel po
sitive nuclei staining were detected in chondrocyte clones in sections of h
uman OA cartilage.
Conclusion: These data suggest that FrzB-2 may play a role in apoptosis and
that the expression of this protein may be important in the pathogenesis o
f human OA. (C) 2000 OsteoArthritis Research Society international.